Methods for Integrating Trials and Non-experimental Data to Examine Treatment Effect Heterogeneity.
Date
2023-11
Journal Title
Journal ISSN
Volume Title
Repository Usage Stats
views
downloads
Citation Stats
Abstract
Estimating treatment effects conditional on observed covariates can improve the ability to tailor treatments to particular individuals. Doing so effectively requires dealing with potential confounding, and also enough data to adequately estimate effect moderation. A recent influx of work has looked into estimating treatment effect heterogeneity using data from multiple randomized controlled trials and/or observational datasets. With many new methods available for assessing treatment effect heterogeneity using multiple studies, it is important to understand which methods are best used in which setting, how the methods compare to one another, and what needs to be done to continue progress in this field. This paper reviews these methods broken down by data setting: aggregate-level data, federated learning, and individual participant-level data. We define the conditional average treatment effect and discuss differences between parametric and nonparametric estimators, and we list key assumptions, both those that are required within a single study and those that are necessary for data combination. After describing existing approaches, we compare and contrast them and reveal open areas for future research. This review demonstrates that there are many possible approaches for estimating treatment effect heterogeneity through the combination of datasets, but that there is substantial work to be done to compare these methods through case studies and simulations, extend them to different settings, and refine them to account for various challenges present in real data.
Type
Department
Description
Provenance
Citation
Permalink
Published Version (Please cite this version)
Publication Info
Brantner, Carly Lupton, Ting-Hsuan Chang, Trang Quynh Nguyen, Hwanhee Hong, Leon Di Stefano and Elizabeth A Stuart (2023). Methods for Integrating Trials and Non-experimental Data to Examine Treatment Effect Heterogeneity. Statistical science : a review journal of the Institute of Mathematical Statistics, 38(4). pp. 640–654. 10.1214/23-sts890 Retrieved from https://hdl.handle.net/10161/31325.
This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.
Collections
Scholars@Duke
Carly Brantner
Carly L. Brantner, PhD, joined the Department of Biostatistics and Bioinformatics and the Duke Clinical Research Institute in 2024. She is both a methodological and collaborative biostatistician. Her methodological background primarily centers around causal inference, focusing on developing and adapting machine learning methods to integrate multiple data sources and estimate heterogeneous treatment effects. She is particularly interested in aiding efficient and effective personalized treatment decisions through robust statistical approaches. She is passionate about impacting health across many areas, including but not limited to female health, mental health, sport science, musculoskeletal systems and function, and aging.
Unless otherwise indicated, scholarly articles published by Duke faculty members are made available here with a CC-BY-NC (Creative Commons Attribution Non-Commercial) license, as enabled by the Duke Open Access Policy. If you wish to use the materials in ways not already permitted under CC-BY-NC, please consult the copyright owner. Other materials are made available here through the author’s grant of a non-exclusive license to make their work openly accessible.